ZADAXIN (thymalfasin)  is intended for subcutaneous injection and should not be given intravenously.   It should be reconstituted with 1.0 ml of the diluent provided, which consists   of 1.0 ml Sterile Water for Injection, immediately prior to use. At the discretion   of the physician, the patient may be taught to self-administer the medication.
 The recommend-ed dose of ZADAXIN (thymalfasin)  for chronic hepatitis B when used as a monotherapy    or in combination with interferon (at the labeled dose and schedule for interferon)    is 1.6 mg (900 µg/m2) administered subcutaneously twice a week for    6 to 12 months. Patients weighing less than 40 kg should receive a ZADAXIN (thymalfasin)  dose    of 40 µg/kg.
 The recommended dose of ZADAXIN (thymalfasin)  for cancer is 1.6 mg (900 µg/m2)    administered subcuta neous-ly using various schedules for 6 months or given    between chemotherapy cycles for the duration of treat-ment.
